The MiSeq System offers the first end-to-end sequencing solution, integrating cluster generation, amplification, sequencing, and data analysis into a single instrument.
MiSeq is the only benchtop sequencer that can produce 2 x 300 paired-end reads and up to 15 Gb of data in a single run. This allows assembly of small genomes or detection of target variants with unmatched accuracy, especially within homopolymer regions. Now, even more samples can be processed in less time while generating more reads per run than any previous versions.
The MiSeq System offers a cost-effective alternative to capillary electrophoresis (CE) for applications such as targeted resequencing, clone checking, and amplicon sequencing.
The MiSeqDx System is the first NGS platform to receive FDA clearance for in vitro diagnostic (IVD) testing.
